Later this 12 months, the FDA plans to resolve whether or not MDMA can be utilized to deal with PTSD
Eva Almqvist/Getty Pictures
disguise caption
toggle caption
Eva Almqvist/Getty Pictures
Later this 12 months, the FDA plans to resolve whether or not MDMA can be utilized to deal with PTSD
Eva Almqvist/Getty Pictures
Folks with post-traumatic stress dysfunction (PTSD) might quickly have a brand new remedy choice: MDMA.
MDMA is the chemical compound discovered within the drug generally known as ecstasy. In August, the Meals and Drug Administration plans to resolve whether or not MDMA will likely be authorised for market based mostly on years of analysis. However severe allegations of analysis misconduct might derail the approval timeline.
NPR science reporter Will Stone talks to host Emily Kwong concerning the medical trials on MDMA-assisted remedy analysis and a latest report questioning the validity of the outcomes.
Learn Will’s full story right here.
Wish to hear us cowl extra tales about well being analysis? Electronic mail us at shortwave@npr.org.
Take heed to Brief Wave on Spotify, Apple Podcasts and Google Podcasts.
Hear to each episode of Brief Wave sponsor-free and assist our work at NPR by signing up for Brief Wave+ at plus.npr.org/shortwave.
This episode was produced by Berly McCoy, edited by Amina Khan and truth checked by Will Stone. Josh Newell was the audio engineer.
